EP1131350A4 - Egf-like nucleic acids and polypeptides and uses thereof - Google Patents

Egf-like nucleic acids and polypeptides and uses thereof

Info

Publication number
EP1131350A4
EP1131350A4 EP99965849A EP99965849A EP1131350A4 EP 1131350 A4 EP1131350 A4 EP 1131350A4 EP 99965849 A EP99965849 A EP 99965849A EP 99965849 A EP99965849 A EP 99965849A EP 1131350 A4 EP1131350 A4 EP 1131350A4
Authority
EP
European Patent Office
Prior art keywords
egf
polypeptides
nucleic acids
nucleic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99965849A
Other languages
German (de)
French (fr)
Other versions
EP1131350A1 (en
Inventor
Samantha Busfield
David P Gearing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of EP1131350A1 publication Critical patent/EP1131350A1/en
Publication of EP1131350A4 publication Critical patent/EP1131350A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99965849A 1998-11-19 1999-11-19 Egf-like nucleic acids and polypeptides and uses thereof Withdrawn EP1131350A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19626998A 1998-11-19 1998-11-19
US196269 1998-11-19
PCT/US1999/027576 WO2000029438A1 (en) 1998-11-19 1999-11-19 Egf-like nucleic acids and polypeptides and uses thereof

Publications (2)

Publication Number Publication Date
EP1131350A1 EP1131350A1 (en) 2001-09-12
EP1131350A4 true EP1131350A4 (en) 2005-05-04

Family

ID=22724690

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99965849A Withdrawn EP1131350A4 (en) 1998-11-19 1999-11-19 Egf-like nucleic acids and polypeptides and uses thereof

Country Status (5)

Country Link
EP (1) EP1131350A4 (en)
JP (1) JP2002530064A (en)
AU (1) AU2153500A (en)
CA (1) CA2351522A1 (en)
WO (1) WO2000029438A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ507728A (en) * 1998-04-29 2002-06-28 Genesis Res & Dev Corp Ltd Information from a cDNA library created from keratinocytes, dermal papilla, neonatal foreskin fibroblast or embryonic skin cells is used to treating cancer, angiogenesis, skin inflammation, inflammatory diseases or stimulating keratinocyte growth
US6573095B1 (en) 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
EP1254246A4 (en) * 2000-01-25 2003-05-21 Hyseq Inc Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
AU2001260847A1 (en) * 2000-05-24 2001-12-03 Genesis Research And Development Corporation Limited Compositions isolated from skin cells and methods for their use
JP2004520345A (en) 2001-01-12 2004-07-08 ワラター・ファーマシューティカルズ・インク Sustained effect of islet cell neoplasia treatment method using gastrin / CCK receptor ligand and EGF receptor ligand composition for subjects with diabetes
US7157558B2 (en) * 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
US7037504B2 (en) 2001-10-23 2006-05-02 Waratah Pharmaceuticals, Inc. Epidermal growth factor protein and gene, and methods of use therefor
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
JP2006506386A (en) 2002-10-22 2006-02-23 ワラタ ファーマシューティカルズ， インコーポレイテッド Diabetes treatment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007736A1 (en) * 1996-08-19 1998-02-26 Millennium Biotherapeutics, Inc. Don-1 gene and polypeptides and uses therefor
WO1999055865A1 (en) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633147A (en) * 1994-03-08 1997-05-27 Human Genome Sciences, Inc. Transforming growth factor αH1
EP0902791A4 (en) * 1996-04-10 2002-10-16 Human Genome Sciences Inc Extracellular/epidermal growth factor hcaba58x
US5892012A (en) * 1997-08-21 1999-04-06 Hillman; Jennifer L. Rab Proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007736A1 (en) * 1996-08-19 1998-02-26 Millennium Biotherapeutics, Inc. Don-1 gene and polypeptides and uses therefor
WO1999055865A1 (en) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0029438A1 *

Also Published As

Publication number Publication date
EP1131350A1 (en) 2001-09-12
JP2002530064A (en) 2002-09-17
AU2153500A (en) 2000-06-05
WO2000029438A9 (en) 2001-01-04
CA2351522A1 (en) 2000-05-25
WO2000029438A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
IL178210A0 (en) Polypeptides and nucleic acids encoding the same
EP1490386A4 (en) Novel polypeptides and nucleic acids encoding the same
EP1242443A4 (en) Novel nucleic acids and polypeptides
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (en) Novel nucleic acids and polypeptides
IL139686A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1341804A4 (en) Novel nucleic acids and polypeptides
EP1276751A4 (en) Novel nucleic acids and polypeptides
EP1155117A4 (en) Secreted proteins and nucleic acids encoding them
EP1131350A4 (en) Egf-like nucleic acids and polypeptides and uses thereof
EP1341803A4 (en) Novel nucleic acids and polypeptides
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
AU6164099A (en) Hrpca 9 and hrpca 10 nucleic acids and polypeptides
ZA988460B (en) Polypeptides and nucleic acids encoding the same
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (en) Novel nucleic acids and polypeptides
IL135446A0 (en) Dakar nucleic acids and polypeptides and methods utilizing the same
AU7005801A (en) Gp354 nucleic acids and polypeptides
EP1274716A4 (en) Novel nucleic acids and polypeptides
AU1837100A (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
AU7298201A (en) Gp286 nucleic acids and polypeptides
IL136693A0 (en) V196 dna and polypeptides
GB0208293D0 (en) Nrage nucleic acids and polypeptides and uses thereof
IL137823A0 (en) Novel polypeptides and nucleic acids encoding the same
EP1254256A4 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010523

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050321

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080603